| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SRRA | Sierra Oncology, Inc. | Vivo Ventures Fund VII, L.P. | Director | Jul 01, 2022 | Option Exercise | $55.00 | 431,947 | 23,757,085 | 0 | Jul 01, 2022, 04:59 PM | |
| SRRA | Sierra Oncology, Inc. | Vivo Ventures VII Affiliates Fund, L.P. | Director | Jul 01, 2022 | Option Exercise | $55.00 | 2,735,853 | 150,471,915 | 0 | Jul 01, 2022, 04:59 PM | |
| SRRA | Sierra Oncology, Inc. | VIVO VENTURES VII, LLC | Director | Jul 01, 2022 | Option Exercise | $55.00 | 161,712 | 8,894,160 | 0 | Jul 01, 2022, 04:59 PM | |
| SRRA | Sierra Oncology, Inc. | OrbiMed Genesis GP LLC | Director | Jul 01, 2022 | Option Exercise | $55.00 | 1,964,770 | 108,062,350 | 0 | Jul 01, 2022, 04:50 PM | |
| SRRA | Sierra Oncology, Inc. | Ashiya Mona | Director | Jul 01, 2022 | Option Exercise | $55.00 | 1,964,770 | 108,062,350 | 0 | Jul 01, 2022, 04:46 PM | |
| SRRA | Sierra Oncology, Inc. | Aggarwal Gaurav | Director | Jul 01, 2022 | Option Exercise | $55.00 | 2,735,853 | 150,471,915 | 0 | Jul 01, 2022, 04:45 PM | |
| SRRA | Sierra Oncology, Inc. | Sinclair Andrew | Director | Jul 01, 2022 | Option Exercise | $55.00 | 1,314,127 | 72,276,985 | 0 | Jul 01, 2022, 04:44 PM | |
| SRRA | Sierra Oncology, Inc. | Klencke Barbara | Chief Medical Officer | Jul 01, 2022 | Option Exercise | $55.00 | 10,000 | 550,000 | 0 | Jul 01, 2022, 04:43 PM | |
| SRRA | Sierra Oncology, Inc. | Klencke Barbara | Chief Medical Officer | Jul 01, 2022 | Option Exercise | $55.00 | 5,000 | 275,000 | 0 | Jul 01, 2022, 04:43 PM | |
| SRRA | Sierra Oncology, Inc. | Allen Andrew R | Director | Jul 01, 2022 | Option Exercise | $55.00 | 1,650 | 90,750 | 0 | Jul 01, 2022, 04:38 PM | |
| SRRA | Sierra Oncology, Inc. | Collard Craig A | Director | Jul 01, 2022 | Option Exercise | $55.00 | 13,500 | 742,500 | 0 | Jul 01, 2022, 04:37 PM | |
| SRRA | Sierra Oncology, Inc. | DILLY STEPHEN GEORGE | CEO and President | Jul 01, 2022 | Option Exercise | $55.00 | 5,000 | 275,000 | 0 | Jul 01, 2022, 04:35 PM | |
| SRRA | Sierra Oncology, Inc. | Turner William D. | Chief Reg & Tech Ops Officer | Apr 05, 2022 | Sale | $24.57 | 200 | 4,914 | 100 | Apr 07, 2022, 04:12 PM | |
| SRRA | Sierra Oncology, Inc. | Turner William D. | Chief Reg & Tech Ops Officer | Apr 06, 2022 | Sale | $24.65 | 12,694 | 312,891 | 6,347 | Apr 07, 2022, 04:12 PM | |
| SRRA | Sierra Oncology, Inc. | Thomson Mary Christina | General Counsel, CCO & Sec'y | Apr 04, 2022 | Sale | $24.09 | 4,000 | 96,357 | 2,000 | Apr 04, 2022, 07:25 PM | |
| SRRA | Sierra Oncology, Inc. | Turner William D. | Chief Reg & Tech Ops Officer | Mar 18, 2022 | Sale | $24.55 | 200 | 4,910 | 100 | Mar 22, 2022, 04:15 PM | |
| SRRA | Sierra Oncology, Inc. | Turner William D. | Chief Reg & Tech Ops Officer | Mar 17, 2022 | Option Exercise | $24.55 | 6,906 | 169,562 | 3,453 | Mar 17, 2022, 06:33 PM | |
| SRRA | Sierra Oncology, Inc. | Thomson Mary Christina | General Counsel, CCO & Sec'y | Mar 04, 2022 | Option Exercise | $21.82 | 4,000 | 87,276 | 2,000 | Mar 04, 2022, 04:12 PM | |
| SRRA | Sierra Oncology, Inc. | Turner William D. | Chief Reg & Tech Ops Officer | Feb 07, 2022 | Option Exercise | $22.19 | 20,000 | 443,725 | 10,000 | Feb 08, 2022, 04:03 PM | |
| SRRA | Sierra Oncology, Inc. | Thomson Mary Christina | General Counsel, CCO & Sec'y | Feb 04, 2022 | Option Exercise | $21.41 | 4,000 | 85,640 | 2,000 | Feb 04, 2022, 04:08 PM | |
| SRRA | Sierra Oncology, Inc. | Longitude Prime Partners, LLC | 10% Owner | Feb 02, 2022 | Buy | $27.00 | 175,000 | 4,725,000 | 175,000 | Feb 02, 2022, 09:25 PM | |
| SRRA | Sierra Oncology, Inc. | Richardson Joshua | Director | Feb 02, 2022 | Buy | $27.00 | 175,000 | 4,725,000 | 175,000 | Feb 02, 2022, 09:24 PM | |
| SRRA | Sierra Oncology, Inc. | Sinclair Andrew | Director | Jan 28, 2022 | Option Exercise | $13.20 | 287,471 | 3,794,617 | 1,164,127 | Feb 01, 2022, 05:04 PM | |
| SRRA | Sierra Oncology, Inc. | Sinclair Andrew | Director | Jan 31, 2022 | Buy | $27.00 | 150,000 | 4,050,000 | 1,314,127 | Feb 01, 2022, 05:04 PM | |
| SRRA | Sierra Oncology, Inc. | Abingworth LLP | 10% Owner | Jan 28, 2022 | Option Exercise | $13.20 | 287,471 | 3,794,617 | 1,164,127 | Feb 01, 2022, 05:00 PM | |
| SRRA | Sierra Oncology, Inc. | Abingworth LLP | 10% Owner | Jan 31, 2022 | Buy | $27.00 | 150,000 | 4,050,000 | 1,314,127 | Feb 01, 2022, 05:00 PM | |
| SRRA | Sierra Oncology, Inc. | Vivo Ventures Fund VII, L.P. | 10% Owner | Jan 31, 2022 | Buy | $27.00 | 800,000 | 21,600,000 | 2,735,853 | Jan 31, 2022, 09:30 PM | |
| SRRA | Sierra Oncology, Inc. | Aggarwal Gaurav | Director | Jan 31, 2022 | Buy | $27.00 | 800,000 | 21,600,000 | 2,735,853 | Jan 31, 2022, 06:47 PM | |
| SRRA | Sierra Oncology, Inc. | Ashiya Mona | Director | Jan 26, 2022 | Option Exercise | $13.20 | 56,244 | 742,421 | 226,704 | Jan 28, 2022, 09:23 PM | |
| SRRA | Sierra Oncology, Inc. | Ashiya Mona | Director | Jan 26, 2022 | Option Exercise | $13.20 | 431,206 | 5,691,919 | 1,511,362 | Jan 28, 2022, 09:23 PM | |
| SRRA | Sierra Oncology, Inc. | OrbiMed Genesis GP LLC | Director | Jan 26, 2022 | Option Exercise | $13.20 | 56,244 | 742,421 | 226,704 | Jan 28, 2022, 09:22 PM | |
| SRRA | Sierra Oncology, Inc. | ORBIMED ADVISORS LLC | Director | Jan 26, 2022 | Option Exercise | $13.20 | 431,206 | 5,691,919 | 1,511,362 | Jan 28, 2022, 09:22 PM | |
| SRRA | Sierra Oncology, Inc. | Vivo Ventures Fund VII, L.P. | 10% Owner | Jan 26, 2022 | Option Exercise | $13.20 | 107,164 | 1,414,565 | 431,947 | Jan 28, 2022, 08:12 PM | |
| SRRA | Sierra Oncology, Inc. | Vivo Opportunity Fund, L.P. | 10% Owner | Jan 26, 2022 | Option Exercise | $13.20 | 480,277 | 6,339,656 | 1,935,853 | Jan 28, 2022, 08:12 PM | |
| SRRA | Sierra Oncology, Inc. | Vivo Ventures VII Affiliates Fund, L.P. | 10% Owner | Jan 26, 2022 | Option Exercise | $13.20 | 24,996 | 329,947 | 161,712 | Jan 28, 2022, 08:12 PM | |
| SRRA | Sierra Oncology, Inc. | Aggarwal Gaurav | Director | Jan 26, 2022 | Option Exercise | $13.20 | 480,277 | 6,339,656 | 1,935,853 | Jan 28, 2022, 07:53 PM | |
| SRRA | Sierra Oncology, Inc. | Thomson Mary Christina | General Counsel & Secretary | Jan 26, 2022 | Sale | $21.02 | 4,000 | 84,080 | 2,000 | Jan 28, 2022, 04:47 PM | |
| SRRA | Sierra Oncology, Inc. | Turner William D. | Chief Reg & Tech Ops Officer | Jan 26, 2022 | Sale | $19.55 | 10,000 | 195,500 | 5,000 | Jan 28, 2022, 04:39 PM | |
| SRRA | Sierra Oncology, Inc. | Tammenoms Bakker Juliet | 10% Owner | Jan 25, 2022 | Option Exercise | $13.20 | 487,451 | 6,434,353 | 1,964,771 | Jan 27, 2022, 09:23 PM | |
| SRRA | Sierra Oncology, Inc. | Richardson Joshua | Director | Jan 25, 2022 | Option Exercise | $13.20 | 487,451 | 6,434,353 | 1,964,771 | Jan 27, 2022, 09:22 PM | |
| SRRA | Sierra Oncology, Inc. | Collard Craig A | Director | Nov 23, 2021 | Buy | $22.94 | 5,601 | 128,515 | 5,601 | Nov 24, 2021, 07:07 PM | |
| SRRA | Sierra Oncology, Inc. | Collard Craig A | Director | Nov 24, 2021 | Buy | $23.08 | 7,899 | 182,348 | 13,500 | Nov 24, 2021, 07:07 PM | |
| SRRA | Sierra Oncology, Inc. | DILLY STEPHEN GEORGE | CEO and President | May 19, 2021 | Buy | $17.83 | 5,000 | 89,150 | 5,000 | May 20, 2021, 06:59 PM | |
| SRRA | Sierra Oncology, Inc. | Klencke Barbara | Chief Development Officer | Aug 18, 2020 | Buy | $12.22 | 5,950 | 72,710 | 10,000 | Aug 18, 2020, 08:16 PM | |
| SRRA | Sierra Oncology, Inc. | Klencke Barbara | Chief Development Officer | Aug 18, 2020 | Buy | $12.25 | 3,325 | 40,738 | 5,000 | Aug 18, 2020, 08:16 PM | |
| SRRA | Sierra Oncology, Inc. | Klencke Barbara | Chief Development Officer | Aug 23, 2019 | Buy | $0.44 | 108,000 | 47,380 | 162,000 | Aug 26, 2019, 05:07 PM | |
| SRRA | Sierra Oncology, Inc. | Klencke Barbara | Chief Development Officer | Aug 22, 2019 | Buy | $0.45 | 54,000 | 24,295 | 54,000 | Aug 26, 2019, 05:07 PM | |
| SRRA | Sierra Oncology, Inc. | Klencke Barbara | Chief Development Officer | Aug 22, 2019 | Buy | $0.43 | 67,000 | 28,964 | 67,000 | Aug 26, 2019, 05:07 PM | |
| SRRA | Sierra Oncology, Inc. | Allen Andrew R | Director | Dec 10, 2018 | Buy | $1.64 | 66,000 | 108,240 | 66,000 | Dec 11, 2018, 05:38 PM | |
| SRRA | Sierra Oncology, Inc. | You Angie | Chief Bus. & Strat. Officer | Mar 08, 2017 | Buy | $1.43 | 30,000 | 42,900 | 133,252 | Mar 09, 2017, 06:01 PM | |
| SRRA | Sierra Oncology, Inc. | Topper James N | Director | Feb 14, 2017 | Buy | $1.35 | 5,925,926 | 8,000,000 | 5,925,926 | Feb 16, 2017, 05:11 PM | |
| DNAI | ProNAi Therapeutics Inc | Chapman Wendy | SVP Clinical Operations | Mar 22, 2016 | Option Exercise | $3.99 | 6,000 | 23,930 | 3,000 | Mar 24, 2016, 05:17 PM | |
| DNAI | ProNAi Therapeutics Inc | Chapman Wendy | SVP Clinical Operations | Feb 22, 2016 | Option Exercise | $4.01 | 6,000 | 24,087 | 3,000 | Feb 24, 2016, 05:07 PM | |
| DNAI | ProNAi Therapeutics Inc | Chapman Wendy | SVP Clinical Operations | Jan 22, 2016 | Sale | $5.18 | 10,000 | 51,818 | 5,000 | Jan 25, 2016, 07:20 PM | |
| DNAI | ProNAi Therapeutics Inc | Rodigueza Wendi | Chief Scientific Officer | Jan 21, 2016 | Sale | $10.32 | 1,000 | 10,323 | 157,276 | Jan 22, 2016, 04:55 PM | |
| DNAI | ProNAi Therapeutics Inc | Rodigueza Wendi | Chief Scientific Officer | Jan 22, 2016 | Sale | $9.66 | 1,000 | 9,660 | 156,276 | Jan 22, 2016, 04:55 PM | |
| DNAI | ProNAi Therapeutics Inc | Rodigueza Wendi | Chief Scientific Officer | Jan 20, 2016 | Sale | $9.59 | 1,000 | 9,590 | 158,276 | Jan 22, 2016, 04:55 PM | |
| DNAI | ProNAi Therapeutics Inc | Glover Nicholas | CEO and President | Jan 15, 2016 | Option Exercise | $5.51 | 10,000 | 55,068 | 5,000 | Jan 19, 2016, 07:00 PM | |
| DNAI | ProNAi Therapeutics Inc | Lovejoy Chandra D | SVP of Reg. Affairs & Quality | Jan 12, 2016 | Sale | $8.56 | 28,524 | 244,150 | 20,973 | Jan 14, 2016, 05:16 PM | |
| DNAI | ProNAi Therapeutics Inc | VIVO VENTURES VII, LLC | Former 10% holder | Jul 21, 2015 | Buy | $13.10 | 321,954 | 4,216,383 | 2,433,577 | Jul 21, 2015, 07:06 PM | |
| DNAI | ProNAi Therapeutics Inc | Vivo Ventures Fund VII, L.P. | Former 10% holder | Jul 21, 2015 | Option Exercise | $13.10 | 7,017 | 91,901 | 2,438,270 | Jul 21, 2015, 07:06 PM | |
| DNAI | ProNAi Therapeutics Inc | Vitangcol Alvin | Director | Jul 21, 2015 | Option Exercise | $5.22 | 39,889 | 208,021 | 798,762 | Jul 21, 2015, 07:05 PM | |
| DNAI | ProNAi Therapeutics Inc | Topper James N | Director | Jul 21, 2015 | Buy | $13.40 | 316,589 | 4,243,712 | 2,186,195 | Jul 21, 2015, 07:04 PM | |
| DNAI | ProNAi Therapeutics Inc | Thompson Peter A. | Director | Jul 21, 2015 | Buy | $13.02 | 264,159 | 3,439,964 | 1,989,949 | Jul 21, 2015, 07:03 PM | |
| DNAI | ProNAi Therapeutics Inc | Parfet Donald R | Chairman of the Board | Jul 21, 2015 | Option Exercise | $5.22 | 4,413 | 23,014 | 142,255 | Jul 21, 2015, 07:02 PM | |
| DNAI | ProNAi Therapeutics Inc | Parfet Donald R | Chairman of the Board | Jul 21, 2015 | Option Exercise | $5.22 | 1,552 | 8,094 | 770,045 | Jul 21, 2015, 07:02 PM | |
| DNAI | ProNAi Therapeutics Inc | Parfet Donald R | Chairman of the Board | Jul 21, 2015 | Option Exercise | $5.22 | 819 | 4,271 | 65,779 | Jul 21, 2015, 07:02 PM | |
| DNAI | ProNAi Therapeutics Inc | Parfet Donald R | Chairman of the Board | Jul 21, 2015 | Option Exercise | $5.22 | 4,119 | 21,481 | 217,903 | Jul 21, 2015, 07:02 PM | |
| DNAI | ProNAi Therapeutics Inc | ISALY SAMUEL D | Director | Jul 21, 2015 | Buy | $13.02 | 264,159 | 3,439,964 | 1,989,949 | Jul 21, 2015, 07:00 PM | |
| DNAI | ProNAi Therapeutics Inc | CHA ALBERT | Director | Jul 21, 2015 | Buy | $13.10 | 321,954 | 4,216,383 | 2,433,577 | Jul 21, 2015, 06:59 PM | |
| DNAI | ProNAi Therapeutics Inc | CHA ALBERT | Director | Jul 21, 2015 | Buy | $13.10 | 7,017 | 91,901 | 2,438,270 | Jul 21, 2015, 06:59 PM |
Menu